Patients treated with RGX-202 demonstrate consistent, robust microdystrophin expression and functional improvement compared to natural history in Phase I/II portion
BRENTWOOD, Tenn., Oct. 30, 2025 /PRNewswire/ -- IntellaTriage, the nation's leading provider of nurse-first triage solutions for hospice and home
BRENTWOOD, Tenn., Oct. 30, 2025 /PRNewswire/ -- IntellaTriage, the nation's leading provider of nurse-first triage solutions for hospice and home
Signs agreement to acquire Keyless, expanding privacy-first authentication across the entire user journey. DENVER, Oct. 30, 2025 /PRNewswire/ -- Ping
Signs agreement to acquire Keyless, expanding privacy-first authentication across the entire user journey. DENVER, Oct. 30, 2025 /PRNewswire/ -- Ping
TAMPA, Fla., Oct. 30, 2025 /PRNewswire/ -- Conexiant is proud to introduce MDspire, an AI-powered discovery and engagement platform transforming
TAMPA, Fla., Oct. 30, 2025 /PRNewswire/ -- Conexiant is proud to introduce MDspire, an AI-powered discovery and engagement platform transforming
—BRINSUPRI ™ (brensocatib) Approved by FDA as First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis; Positive CHMP Opinion Adopted in
—BRINSUPRI ™ (brensocatib) Approved by FDA as First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis; Positive CHMP Opinion Adopted in